In this live, Dr. Diamantopoulos discusses the benefits of DES and DCB over BMS and POBA, highlighting their role in reducing restenosis rates and the need for reintervention. He also addresses the safety profiles of these technologies, considering factors such as paclitaxel safety and the implications of recent findings. The webinar includes a review of clinical studies supporting the efficacy of DES and DCB in PAD treatment.
To watch the full webinar, click here :
This playlist includes 4 video extracts from the DET SHOW 2025: - Live case procedure from UK - Restenosis challenge - Drug-Eluting Technologies in PAD: DES and DCB vs BMS and PO...